Report Detail

Medical Devices & Consumables COVID-19 Impact on Global Wearable Injector Devices Market Insights, Forecast to 2026

  • RnM4071130
  • |
  • 22 June, 2020
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Wearable Injector Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Wearable Injector Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Wearable Injector Devices market is segmented into
Disposable
Reusable

Segment by Application, the Wearable Injector Devices market is segmented into
Oncology
Diabetes
Cardiovascular Diseases
Autoimmune Disorder
Infectious Diseases
Others

Regional and Country-level Analysis
The Wearable Injector Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Wearable Injector Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Wearable Injector Devices Market Share Analysis

Wearable Injector Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Wearable Injector Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Wearable Injector Devices business, the date to enter into the Wearable Injector Devices market, Wearable Injector Devices product introduction, recent developments, etc.
The major vendors covered:
SteadyMed Therapeutics, Inc.
UNILIFE CORPORATION
Sensile Medical AGInsulet Corporation
Enable Injections
Becton
West Pharmaceutical Services, Inc.
Ypsomed
Amgen
Buhler Motor GmbH
F. Hoffmann-La Roche Ltd
Johnson & Johnson Services, Inc.


1 Study Coverage

  • 1.1 Wearable Injector Devices Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Wearable Injector Devices Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Wearable Injector Devices Market Size Growth Rate by Type
    • 1.4.2 Disposable
    • 1.4.3 Reusable
  • 1.5 Market by Application
    • 1.5.1 Global Wearable Injector Devices Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Diabetes
    • 1.5.4 Cardiovascular Diseases
    • 1.5.5 Autoimmune Disorder
    • 1.5.6 Infectious Diseases
    • 1.5.7 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Wearable Injector Devices Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Wearable Injector Devices Industry
      • 1.6.1.1 Wearable Injector Devices Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Wearable Injector Devices Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Wearable Injector Devices Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Wearable Injector Devices Market Size Estimates and Forecasts
    • 2.1.1 Global Wearable Injector Devices Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Wearable Injector Devices Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Wearable Injector Devices Production Estimates and Forecasts 2015-2026
  • 2.2 Global Wearable Injector Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Wearable Injector Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Wearable Injector Devices Manufacturers Geographical Distribution
  • 2.4 Key Trends for Wearable Injector Devices Markets & Products
  • 2.5 Primary Interviews with Key Wearable Injector Devices Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Wearable Injector Devices Manufacturers by Production Capacity
    • 3.1.1 Global Top Wearable Injector Devices Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Wearable Injector Devices Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Wearable Injector Devices Manufacturers Market Share by Production
  • 3.2 Global Top Wearable Injector Devices Manufacturers by Revenue
    • 3.2.1 Global Top Wearable Injector Devices Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Wearable Injector Devices Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Wearable Injector Devices Revenue in 2019
  • 3.3 Global Wearable Injector Devices Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Wearable Injector Devices Production by Regions

  • 4.1 Global Wearable Injector Devices Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Wearable Injector Devices Regions by Production (2015-2020)
    • 4.1.2 Global Top Wearable Injector Devices Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Wearable Injector Devices Production (2015-2020)
    • 4.2.2 North America Wearable Injector Devices Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Wearable Injector Devices Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Wearable Injector Devices Production (2015-2020)
    • 4.3.2 Europe Wearable Injector Devices Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Wearable Injector Devices Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Wearable Injector Devices Production (2015-2020)
    • 4.4.2 China Wearable Injector Devices Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Wearable Injector Devices Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Wearable Injector Devices Production (2015-2020)
    • 4.5.2 Japan Wearable Injector Devices Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Wearable Injector Devices Import & Export (2015-2020)

5 Wearable Injector Devices Consumption by Region

  • 5.1 Global Top Wearable Injector Devices Regions by Consumption
    • 5.1.1 Global Top Wearable Injector Devices Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Wearable Injector Devices Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Wearable Injector Devices Consumption by Application
    • 5.2.2 North America Wearable Injector Devices Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Wearable Injector Devices Consumption by Application
    • 5.3.2 Europe Wearable Injector Devices Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Wearable Injector Devices Consumption by Application
    • 5.4.2 Asia Pacific Wearable Injector Devices Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Wearable Injector Devices Consumption by Application
    • 5.5.2 Central & South America Wearable Injector Devices Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Wearable Injector Devices Consumption by Application
    • 5.6.2 Middle East and Africa Wearable Injector Devices Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Wearable Injector Devices Market Size by Type (2015-2020)
    • 6.1.1 Global Wearable Injector Devices Production by Type (2015-2020)
    • 6.1.2 Global Wearable Injector Devices Revenue by Type (2015-2020)
    • 6.1.3 Wearable Injector Devices Price by Type (2015-2020)
  • 6.2 Global Wearable Injector Devices Market Forecast by Type (2021-2026)
    • 6.2.1 Global Wearable Injector Devices Production Forecast by Type (2021-2026)
    • 6.2.2 Global Wearable Injector Devices Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Wearable Injector Devices Price Forecast by Type (2021-2026)
  • 6.3 Global Wearable Injector Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Wearable Injector Devices Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Wearable Injector Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 SteadyMed Therapeutics, Inc.
    • 8.1.1 SteadyMed Therapeutics, Inc. Corporation Information
    • 8.1.2 SteadyMed Therapeutics, Inc. Overview and Its Total Revenue
    • 8.1.3 SteadyMed Therapeutics, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 SteadyMed Therapeutics, Inc. Product Description
    • 8.1.5 SteadyMed Therapeutics, Inc. Recent Development
  • 8.2 UNILIFE CORPORATION
    • 8.2.1 UNILIFE CORPORATION Corporation Information
    • 8.2.2 UNILIFE CORPORATION Overview and Its Total Revenue
    • 8.2.3 UNILIFE CORPORATION Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 UNILIFE CORPORATION Product Description
    • 8.2.5 UNILIFE CORPORATION Recent Development
  • 8.3 Sensile Medical AGInsulet Corporation
    • 8.3.1 Sensile Medical AGInsulet Corporation Corporation Information
    • 8.3.2 Sensile Medical AGInsulet Corporation Overview and Its Total Revenue
    • 8.3.3 Sensile Medical AGInsulet Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Sensile Medical AGInsulet Corporation Product Description
    • 8.3.5 Sensile Medical AGInsulet Corporation Recent Development
  • 8.4 Enable Injections
    • 8.4.1 Enable Injections Corporation Information
    • 8.4.2 Enable Injections Overview and Its Total Revenue
    • 8.4.3 Enable Injections Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Enable Injections Product Description
    • 8.4.5 Enable Injections Recent Development
  • 8.5 Becton
    • 8.5.1 Becton Corporation Information
    • 8.5.2 Becton Overview and Its Total Revenue
    • 8.5.3 Becton Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Becton Product Description
    • 8.5.5 Becton Recent Development
  • 8.6 West Pharmaceutical Services, Inc.
    • 8.6.1 West Pharmaceutical Services, Inc. Corporation Information
    • 8.6.2 West Pharmaceutical Services, Inc. Overview and Its Total Revenue
    • 8.6.3 West Pharmaceutical Services, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 West Pharmaceutical Services, Inc. Product Description
    • 8.6.5 West Pharmaceutical Services, Inc. Recent Development
  • 8.7 Ypsomed
    • 8.7.1 Ypsomed Corporation Information
    • 8.7.2 Ypsomed Overview and Its Total Revenue
    • 8.7.3 Ypsomed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Ypsomed Product Description
    • 8.7.5 Ypsomed Recent Development
  • 8.8 Amgen
    • 8.8.1 Amgen Corporation Information
    • 8.8.2 Amgen Overview and Its Total Revenue
    • 8.8.3 Amgen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Amgen Product Description
    • 8.8.5 Amgen Recent Development
  • 8.9 Buhler Motor GmbH
    • 8.9.1 Buhler Motor GmbH Corporation Information
    • 8.9.2 Buhler Motor GmbH Overview and Its Total Revenue
    • 8.9.3 Buhler Motor GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Buhler Motor GmbH Product Description
    • 8.9.5 Buhler Motor GmbH Recent Development
  • 8.10 F. Hoffmann-La Roche Ltd
    • 8.10.1 F. Hoffmann-La Roche Ltd Corporation Information
    • 8.10.2 F. Hoffmann-La Roche Ltd Overview and Its Total Revenue
    • 8.10.3 F. Hoffmann-La Roche Ltd Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 F. Hoffmann-La Roche Ltd Product Description
    • 8.10.5 F. Hoffmann-La Roche Ltd Recent Development
  • 8.11 Johnson & Johnson Services, Inc.
    • 8.11.1 Johnson & Johnson Services, Inc. Corporation Information
    • 8.11.2 Johnson & Johnson Services, Inc. Overview and Its Total Revenue
    • 8.11.3 Johnson & Johnson Services, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Johnson & Johnson Services, Inc. Product Description
    • 8.11.5 Johnson & Johnson Services, Inc. Recent Development
  • 8.12 CeQur SA.
    • 8.12.1 CeQur SA. Corporation Information
    • 8.12.2 CeQur SA. Overview and Its Total Revenue
    • 8.12.3 CeQur SA. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 CeQur SA. Product Description
    • 8.12.5 CeQur SA. Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top Wearable Injector Devices Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Wearable Injector Devices Regions Forecast by Production (2021-2026)
  • 9.3 Key Wearable Injector Devices Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Wearable Injector Devices Consumption Forecast by Region

  • 10.1 Global Wearable Injector Devices Consumption Forecast by Region (2021-2026)
  • 10.2 North America Wearable Injector Devices Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Wearable Injector Devices Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Wearable Injector Devices Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Wearable Injector Devices Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Wearable Injector Devices Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Wearable Injector Devices Sales Channels
    • 11.2.2 Wearable Injector Devices Distributors
  • 11.3 Wearable Injector Devices Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Wearable Injector Devices Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Wearable Injector Devices. Industry analysis & Market Report on COVID-19 Impact on Global Wearable Injector Devices is a syndicated market report, published as COVID-19 Impact on Global Wearable Injector Devices Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Wearable Injector Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,939.60
    5,909.40
    7,879.20
    4,581.50
    6,872.25
    9,163.00
    758,079.00
    1,137,118.50
    1,516,158.00
    408,317.00
    612,475.50
    816,634.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report